Latest news
Loading news…
Tarsus Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Irvine, California, United States Founded 2017 251-500 employees For Profit
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Tarsus Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$475.6M
Funding Rounds
6
Last Funding
Acquisitions
1
Monthly Visits
Contacts
220
Ticker
TARS
NASDAQ
About Tarsus Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- TARS
- Exchange
- NASDAQ
- IPO date
- Oct 15, 2020
- Raised at IPO
- $88M
- Valuation at IPO
- $308.14M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 25
- IT spend
- $7.94M
Company Info
- Founded
- 2017
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 168
- HQ
- Irvine, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
- Exit date
- Oct 15, 2020
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 4.6
- Trend (30d)
- 3.7
- Trend (90d)
- 7.4
- Last leadership hire
- Jul 13, 2026
Tarsus Pharmaceuticals Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
Tarsus Pharmaceuticals Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Alkeus Pharmaceuticals | $270M | 2026-08-06 | Tarsus Pharmaceuticals | BiotechnologyMedicalPharmaceutical | United States |
| iRenix Medical | $75M | 2026-06-06 | Tarsus Pharmaceuticals | Health CareManufacturingMedical | United States |
1–2 of 2Show
Page 1 / 1
Tarsus Pharmaceuticals Key People
President and CEO
Chief Medical Officer
Chief Financial Officer and Chief Strategy Officer
220
professional contacts at Tarsus Pharmaceuticals
Contact execs at Tarsus Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Tarsus Pharmaceuticals
Loading news…
FAQs about Tarsus Pharmaceuticals
People who checked this page also checked these
Sectors Tarsus Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.